Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Quality glucose information is a core prerequisite for successful diabetes management.It enables professionals and people with diabetes to make medically relevant decisions on therapy.Details of glucose profile information beyond HbA 1c have been largely derived from self-monitoring of blood glucose (SMBG).Given the evidence base demonstrating the benefits of SMBG, its routine use is recommended for diabetes management and therapy by many international and regional guidelines (1-3).Today, SMBG is considered an important aspect of the management of glycemic control (3,4).Glucose information of high quality, considering the products used and the processes conducted, is also needed in clinical research in order to gain new evidence and insights on effective treatment strategies in diabetes.SMBG is widely and routinely applied in large clinical trials, where it is used to understand the glycemic state, to enhance awareness of the effects of lifestyle modification and the adaptation of treatment including insulin titration, and to enable documentation of intraday pre-and postprandial glucose excursions (glycemic variability) and the subsequent statistical analysis of this and the confirmation of hypoglycemic episodes.Examples of recent studies that used SMBG are Outcome Reduction With Initial Glargine Intervention (ORIGIN) trial, Action to Control Cardiovascular Risk in Diabetes (ACCORD), and, from earlier times, the Diabetes Control and Complications Trial (DCCT) (5-8).Indeed, SMBG is now applied in most studies of glucoselowering agents, including glucagon-like peptide 1 (GLP-1) receptor agonist and sodium-glucose cotransporter 2 (SGLT2) inhibitor studies.Reliable glucose information requires a clear definition as part of the study design and protocol, not least to ensure replication of the methodology.Interpretation and comparison of study results may be affected if SMBG methods and results are addressed inconsistently.With regard to the interpretation of outcomes of studies, reporting of SMBG in publications should be of the highest qualitydaccurate, precise, reliable, and reproducible.In many publications, however, relevant details of the SMBG measures are lacking or are incomplete.Therefore, the interpretation of study results may be hampered, reliability of study results may be compromised, and repetition of trials may become necessary.This consensus publication not only aims to summarize learnings from previous clinical studies about the use and reporting of SMBG but also proposes recommendations for the description of the performance and reporting of SMBG in future clinical study protocols and related publications.Clinical trials aim at expanding knowledge and evidence.One major principle of Good Clinical Practice is to conduct clinical studies at a quality standard that provides the highest level of safety for the study participants but also avoids a potentially unnecessary burden on participants by inefficient repetition of the experiments with "human beings" to answer a clinical/scientific question.In clinical trials, SMBG is performed by participants to provide information on (fluctuating) blood glucose concentrations and as a means to guide titration (as per protocol).All current tests require pricking a finger with a lancet device to obtain a small blood sample and applying a drop of blood to a test strip or tape, with the glucose concentration analyzed by a glucose meter for an automated reading.Test results are stored in the blood glucose meter's electronic memory for further use (9).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
Nauck, M., Frid, A., Hermansen, K., Shah, N. S., Tankova, T., Mitha, I. H., Zdravkovic, M., Düring, M., Matthews, D. R., & for the LEAD-2 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-1355 · Cited by 1,129
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429
Self-citationGlucose Meters: A Review of Technical Challenges to Obtaining Accurate Results
Tonyushkina, K., & Nichols, J. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300446 · Cited by 406
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Malanda, U. L., Welschen, L. M., Riphagen, I. I., Dekker, J. M., Nijpels, G., & Bot, S. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub3 · Cited by 358
Factors affecting blood glucose monitoring: sources of errors in measurement
Ginsberg, B. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300438 · Cited by 348
Nalysnyk, L., Hernandez‐Medina, M., & Krishnarajah, G. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01160.x · Cited by 343
Guerci, B., Drouin, P., Grangé, V, Bougnères, P., Fontaine, P., Kerlan, V, Passa, P., Thivolet, C., Vialettes, B., & Charbonnel, B. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70073-3 · Cited by 287 · cited 1×
“in insulin-treated and noninsulin-treated patients with diabetes has been increasing in the last decade (13,14).”
BackgroundSelf-citationMartin, S., Schneider, B., Heinemann, L., Lodwig, V., Kurth, H.-J., Kolb, H., Scherbaum, W. A., & for the ROSSO Study Group (2006) · Diabetologia · doi:10.1007/s00125-005-0083-5 · Cited by 284 · cited 2×
“be remembered that SMBG is not a therapeutic tool but rather a diagnostic and monitoring tool and should be performed with a structured educational and therapeutic format in response to SMBG data (11,36).”
BackgroundSelf-monitoring of blood glucose in type 2 diabetes: systematic review
Clar, C., Barnard, K., Cummins, E., Royle, P., & Waugh, N. (2010) · Health Technology Assessment · doi:10.3310/hta14120 · Cited by 274
Self-citationFarmer, A. J., Perera, R., Ward, A., Heneghan, C., Oke, J., Barnett, A. H., Davidson, M. B., Guerci, B., Coates, V., Schwedes, U., et al. (2012) · BMJ · doi:10.1136/bmj.e486 · Cited by 156
Self-citationBreton, M. D., & Kovatchev, B. P. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400309 · Cited by 103
Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies
Schnell, O., Alawi, H., Battelino, T., Ceriello, A., Diem, P., Felton, A.-M., Grzeszczak, W., Harno, K., Kempler, P., Satman, I., et al. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700225 · Cited by 88 · cited 3×
“starting SMBG has been emphasized (12).”
BackgroundSelf-citationSwinnen, S. G. H. A., Mullins, P., Miller, M., Hoekstra, J. B. L., & Holleman, F. (2009) · Diabetologia · doi:10.1007/s00125-008-1147-0 · Cited by 52
Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
Welschen, L. M., Bloemendal, E., Nijpels, G., Dekker, J. M., Heine, R. J., Stalman, W. A., & Bouter, L. M. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005060.pub2 · Cited by 51
Moreland, E. C., Volkening, L. K., Lawlor, M. T., Chalmers, K. A., Anderson, B. J., & Laffel, L. M. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.6.689 · Cited by 2 · cited 3×
“ing and prevention of hyperglycemia/ hypoglycemia The STeP (Structured Testing Program) study in people with type 2 diabetes, as a useful example for a study on SMBG, demonstrated structured SMBG contributing significantly to the improvement in glycemic control and psychosocial functioning compared with enhanced usual…”
BackgroundSelf-citation
Cited by
Portable out-of-hospital electrocardiography: A review of current technologies
Bansal, A., & Joshi, R. (2018) · Journal of Arrhythmia · doi:10.1002/joa3.12035 · Cited by 174
Lee, J. Y., Chan, C. K. Y., Chua, S. S., Paraidathathu, T., Lee, K. K.-C., Tan, C. S. S., Nasir, N., & Lee, S. W. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026575 · Cited by 60
Cersosimo, E., Johnson, E. L., Chovanes, C., & Skolnik, N. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13108 · Cited by 52
Grady, M., Lamps, G., Shemain, A., Cameron, H., & Murray, L. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819856665 · Cited by 18
Kaveh, M. H., Faradonbeh, M. R., & Kaveh, S. (2024) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x211052222 · Cited by 12
Metadata
- Authors
- Schnell, O., Barnard, K., Bergenstal, R., Bosi, E., Garg, S., Guerci, B., Haak, T., Hirsch, I. B., Ji, L., Joshi, S. R., Kamp, M., Laffel, L., Mathieu, C., Polonsky, W. H., Snoek, F., & Home, P.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-08-10
- Volume
- 38
- Issue
- 9
- Pages
- 1627-1633
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2117349244
- Cited by
- 36
- References
- 17
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.